肺移植和辅助肺康复后右心室功能改善:心声图分析
Meltem Altınsoy1, Deniz Çelik2, Fadime Bozduman Habip3
1Etlik City Hospital, 06170 Ankara, Turkey.
Journal of clinical medicine
|January 28, 2026
概括
肺移植与肺康复 (PR) 结合,改善了右心室 (RV) 功能,正如通过斑点追踪心声学 (STE) 增强RV心肌变形所显示的那样. 在移植后,STE可以检测RV的早期恢复,即使传统措施是正常的.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 移植医学 移植医学
- 心声回声扫描 (Echocardiography) 是一种心声回声扫描.
背景情况:
- 由于慢性压力过载,右心室 (RV) 功能障碍在晚期肺部疾病中很普遍.
- 肺移植 (LTx) 减少了RV后负荷,肺康复 (PR) 可能进一步帮助功能恢复.
- 需要进一步描述LTx和PR对VR心肌变形的联合影响,特别是通过斑点追踪心电回声学 (STE).
研究的目的:
- 评估结构化肺康复 (PR) 计划对肺移植 (LTx) 接受者的右心室 (RV) 心肌变形的影响.
- 评估与传统回声心脏指数相比,斑点追踪回声心脏学 (STE) 参数在检测LTx后早期RV变化的灵敏度.
主要方法:
- 这是一项单臂前后研究,涉及20名双边肺移植接受者.
- 参与者接受了为期8周的监督门诊肺部康复 (PR) 计划.
- 在PR前和之后进行了心声评估,包括STE衍生菌株参数 (RV全球纵向菌株-RVGLS,RV自由壁纵向菌株-RVFWS).
主要成果:
- 在PR后观察到RV心肌变形的显著改善,RVGLS增加 (p=0.004) 和RVFWS增加 (p=0.001).
- RV中腔直径显著减少 (p=0.042),表明有利的RV几何变化.
- 传统的心声回声学参数 (TAPSE,S'速度,RVEDA,FAC) 没有显著变化,这表明STE在早期RV重塑检测方面具有更高的灵敏度.
结论:
- 肺移植与结构化PR计划相结合,导致RV变形指数的早期改善,可以通过STE测量.
- STE是一种敏感的工具,用于监测LTx后的亚临床RV恢复,并评估PR的附加效益.
- 当常规心声学指数保持在正常范围内时,STE可以检测LTx和PR后VR功能的改善.
更多相关视频
07:38Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
Published on: January 20, 2023
4.7K
05:56Author Spotlight: Enhancing Diagnostic Strategies and Biomarker Development for Comprehensive Lung Function Analysis
Published on: August 9, 2024
2.5K
相关概念视频
Pulmonary Function Tests
797
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
797
Lung Capacity
56.2K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.2K
Heart Failure VI: Adjunct Therapies
314
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
314
Pulmonary Tuberculosis I
923
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
923
Pulmonary Tuberculosis II
1.5K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.5K
Pulmonary Tuberculosis V
586
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
586
